Sectoral Asset Management’s AgomAb Therapeutics NV AGMB Stock Holding History
Bought
Maintained
Sold
Other funds holding AGMB
SL
Sectoral Asset Management's AGMB Position: Q3 2026 in Review
Sectoral Asset Management sold out of AgomAb Therapeutics NV (AGMB) in Q3 2026, closing a stake of 43,500 shares — an estimated $565K sold.
Sectoral Asset Management first reported a position in AGMB in Q1 2026 and held it in 2 quarters. The position peaked at $565K in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.
- Sectoral Asset Management reported no remaining AgomAb Therapeutics NV position as of Q3 2026 after selling out during the quarter.
- Sectoral Asset Management sold 43,500 AgomAb Therapeutics NV shares in Q3 2026, an estimated $565K.
- Sectoral Asset Management first reported a position in AgomAb Therapeutics NV in Q1 2026 and held it in 2 quarters.
- Sectoral Asset Management's AgomAb Therapeutics NV position peaked at $565K in Q2 2026.
- 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.
Based on Sectoral Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.